Neurocrine Biosciences IncNASDAQ:NBIX
- LAST PRICE135.9900
- TODAY'S CHANGE (%)-1.7700 (-1.2848%)
- Bid / Lots125.0000/ 1
- Ask / Lots144.2000/ 2
- Open / Previous Close137.4700 / 137.7600
- Day Range
- 52 Week Range
- Volume717,575
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NBIX |
|---|---|---|
| 09:32 ET | 4595 | 137.47 |
| 09:34 ET | 241 | 138.17 |
| 09:36 ET | 1200 | 137.68 |
| 09:43 ET | 200 | 138.35 |
| 09:45 ET | 100 | 138.285 |
| 09:48 ET | 661 | 138.19 |
| 09:50 ET | 100 | 138.05 |
| 09:54 ET | 200 | 138.04 |
| 09:56 ET | 100 | 138.16 |
| 09:57 ET | 300 | 138.07 |
| 09:59 ET | 800 | 137.97 |
| 10:01 ET | 200 | 137.985 |
| 10:03 ET | 6409 | 138.1 |
| 10:06 ET | 100 | 138.17 |
| 10:08 ET | 100 | 138 |
| 10:10 ET | 2523 | 137.74 |
| 10:12 ET | 1457 | 137.545 |
| 10:14 ET | 600 | 137.7 |
| 10:15 ET | 100 | 137.5 |
| 10:17 ET | 400 | 137.09 |
| 10:19 ET | 1923 | 136.81 |
| 10:21 ET | 300 | 136.62 |
| 10:24 ET | 1260 | 136.67 |
| 10:26 ET | 1100 | 136.36 |
| 10:28 ET | 1100 | 136.03 |
| 10:30 ET | 8495 | 136.45 |
| 10:32 ET | 200 | 136.45 |
| 10:33 ET | 5189 | 136.28 |
| 10:35 ET | 400 | 136.23 |
| 10:37 ET | 3100 | 136.075 |
| 10:39 ET | 1600 | 135.82 |
| 10:42 ET | 4973 | 136.17 |
| 10:44 ET | 1240 | 136.12 |
| 10:46 ET | 501 | 136.09 |
| 10:48 ET | 500 | 135.93 |
| 10:50 ET | 1200 | 136.05 |
| 10:51 ET | 2629 | 136.03 |
| 10:53 ET | 100 | 136.38 |
| 10:55 ET | 252 | 136.55 |
| 10:57 ET | 500 | 136.885 |
| 11:00 ET | 900 | 136.955 |
| 11:02 ET | 4047 | 137.33 |
| 11:04 ET | 362 | 137.4025 |
| 11:06 ET | 5123 | 137.03 |
| 11:08 ET | 738 | 136.78 |
| 11:09 ET | 3600 | 136.68 |
| 11:11 ET | 700 | 136.86 |
| 11:13 ET | 300 | 136.81 |
| 11:15 ET | 754 | 136.79 |
| 11:18 ET | 300 | 136.75 |
| 11:20 ET | 526 | 136.995 |
| 11:22 ET | 362 | 137.08 |
| 11:24 ET | 300 | 137.02 |
| 11:26 ET | 1200 | 136.86 |
| 11:27 ET | 2010 | 136.81 |
| 11:29 ET | 2586 | 136.5 |
| 11:31 ET | 5414 | 136.77 |
| 11:33 ET | 374 | 137.13 |
| 11:36 ET | 800 | 136.59 |
| 11:38 ET | 410 | 136.57 |
| 11:40 ET | 1208 | 136.715 |
| 11:42 ET | 100 | 136.72 |
| 11:44 ET | 100 | 136.78 |
| 11:45 ET | 300 | 136.88 |
| 11:47 ET | 600 | 136.8 |
| 11:49 ET | 889 | 136.94 |
| 11:51 ET | 301 | 136.865 |
| 11:54 ET | 200 | 136.83 |
| 11:56 ET | 4535 | 136.685 |
| 12:00 ET | 472 | 136.6321 |
| 12:02 ET | 500 | 136.44 |
| 12:03 ET | 500 | 136.39 |
| 12:05 ET | 614 | 136.605 |
| 12:07 ET | 200 | 136.51 |
| 12:09 ET | 1284 | 136.62 |
| 12:12 ET | 1455 | 136.725 |
| 12:14 ET | 799 | 136.485 |
| 12:16 ET | 400 | 136.39 |
| 12:18 ET | 100 | 136.38 |
| 12:21 ET | 400 | 136.475 |
| 12:23 ET | 100 | 136.41 |
| 12:25 ET | 300 | 136.39 |
| 12:27 ET | 500 | 136.405 |
| 12:30 ET | 1678 | 136.535 |
| 12:32 ET | 152 | 136.59 |
| 12:34 ET | 500 | 136.51 |
| 12:36 ET | 2500 | 136.43 |
| 12:38 ET | 415 | 136.32 |
| 12:39 ET | 2935 | 136.37 |
| 12:41 ET | 100 | 136.45 |
| 12:43 ET | 627 | 136.32 |
| 12:48 ET | 3148 | 136.315 |
| 12:52 ET | 500 | 136.24 |
| 12:54 ET | 1621 | 136.515 |
| 12:56 ET | 600 | 136.74 |
| 01:01 ET | 204 | 136.88 |
| 01:03 ET | 518 | 136.78 |
| 01:06 ET | 700 | 136.65 |
| 01:08 ET | 100 | 136.66 |
| 01:10 ET | 1400 | 136.91 |
| 01:12 ET | 310 | 136.81 |
| 01:14 ET | 200 | 136.85 |
| 01:15 ET | 100 | 136.93 |
| 01:17 ET | 100 | 137.02 |
| 01:19 ET | 100 | 137.035 |
| 01:21 ET | 2300 | 136.765 |
| 01:24 ET | 3581 | 136.66 |
| 01:26 ET | 2527 | 136.37 |
| 01:28 ET | 5934 | 136.285 |
| 01:30 ET | 900 | 136.02 |
| 01:32 ET | 4128 | 136.23 |
| 01:33 ET | 11511 | 136.39 |
| 01:35 ET | 300 | 136.18 |
| 01:37 ET | 150 | 136.0679 |
| 01:39 ET | 500 | 135.955 |
| 01:42 ET | 3331 | 136.24 |
| 01:44 ET | 760 | 136.425 |
| 01:46 ET | 1092 | 136.39 |
| 01:48 ET | 398 | 136.39 |
| 01:50 ET | 2116 | 136.32 |
| 01:51 ET | 843 | 136.18 |
| 01:53 ET | 1700 | 136.11 |
| 01:55 ET | 1060 | 136.23 |
| 01:57 ET | 264 | 136.09 |
| 02:00 ET | 300 | 136.165 |
| 02:02 ET | 5804 | 136.3134 |
| 02:04 ET | 1343 | 136.14 |
| 02:06 ET | 5355 | 136.05 |
| 02:08 ET | 4128 | 136.11 |
| 02:09 ET | 1443 | 136.03 |
| 02:11 ET | 800 | 136 |
| 02:13 ET | 7500 | 136.6 |
| 02:15 ET | 300 | 136.7 |
| 02:18 ET | 478 | 136.76 |
| 02:20 ET | 1302 | 136.49 |
| 02:22 ET | 917 | 136.35 |
| 02:24 ET | 1000 | 136.28 |
| 02:26 ET | 611 | 136.21 |
| 02:27 ET | 100 | 136.28 |
| 02:29 ET | 628 | 136.18 |
| 02:31 ET | 301 | 136.32 |
| 02:33 ET | 653 | 136.215 |
| 02:36 ET | 826 | 136.355 |
| 02:38 ET | 800 | 136.32 |
| 02:40 ET | 2226 | 136.27 |
| 02:42 ET | 200 | 136.305 |
| 02:44 ET | 1354 | 136.25 |
| 02:45 ET | 500 | 136.13 |
| 02:47 ET | 1132 | 136.2875 |
| 02:49 ET | 500 | 136.09 |
| 02:51 ET | 400 | 136.09 |
| 02:54 ET | 1729 | 136.455 |
| 02:56 ET | 300 | 136.355 |
| 02:58 ET | 400 | 136.29 |
| 03:00 ET | 1400 | 136.368603 |
| 03:02 ET | 900 | 136.18 |
| 03:03 ET | 2599 | 136.05 |
| 03:05 ET | 500 | 136.03 |
| 03:07 ET | 1398 | 136.125 |
| 03:09 ET | 800 | 136.1 |
| 03:12 ET | 3571 | 136.16 |
| 03:14 ET | 1000 | 136.02 |
| 03:16 ET | 1200 | 136.095 |
| 03:18 ET | 6819 | 136.33 |
| 03:20 ET | 1600 | 136.07 |
| 03:21 ET | 2800 | 135.995 |
| 03:23 ET | 3083 | 135.91 |
| 03:25 ET | 5000 | 135.69 |
| 03:27 ET | 12599 | 135.51 |
| 03:30 ET | 4784 | 135.675 |
| 03:32 ET | 1700 | 135.59 |
| 03:34 ET | 7567 | 135.38 |
| 03:36 ET | 4266 | 135.515 |
| 03:38 ET | 2860 | 135.55 |
| 03:39 ET | 2853 | 135.51 |
| 03:41 ET | 4052 | 135.74 |
| 03:43 ET | 1600 | 135.67 |
| 03:45 ET | 2400 | 135.43 |
| 03:48 ET | 3200 | 135.32 |
| 03:50 ET | 4248 | 135.31 |
| 03:52 ET | 5500 | 135.51 |
| 03:54 ET | 4007 | 135.44 |
| 03:56 ET | 6774 | 135.84 |
| 03:57 ET | 7597 | 135.89 |
| 03:59 ET | 13447 | 135.99 |
Apr 24, 2024
DJ Neurocrine Raised to Overweight From Equal-Weight by Wells Fargo, from 10:23AM ET on Wednesday Apr 24, 2024 by Dow Jones
10:23AM ET on Wednesday Apr 24, 2024 by Dow JonesNeurocrine Biosciences Launches WHAT THE C@H?! Educational Initiative to Support Congenital Adrenal Hyperplasia Community, from 8:30AM ET on Wednesday Apr 24, 2024 by Dow Jones
8:30AM ET on Wednesday Apr 24, 2024 by Dow JonesDJ Neurocrine Is Maintained at Outperform by Oppenheimer, from 7:35AM ET on Wednesday Apr 24, 2024 by Dow Jones
7:35AM ET on Wednesday Apr 24, 2024 by Dow JonesDJ Neurocrine Price Target Maintained With a $150.00/Share by HC Wainwright & Co., from 6:15AM ET on Wednesday Apr 24, 2024 by Dow Jones
6:15AM ET on Wednesday Apr 24, 2024 by Dow Jones
Apr 23, 2024
DJ S&P 500 Futures Climb In Premarket Trading; Danaher, Spotify Technology Lead, from 7:31AM ET on Tuesday Apr 23, 2024 by Dow Jones
7:31AM ET on Tuesday Apr 23, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Neurocrine Biosciences Inc | 13.9B | 55.9x | +62.04% |
Medpace Holdings Inc | 12.1B | 40.3x | +35.10% |
Alnylam Pharmaceuticals Inc | 18.1B | -39.9x | --- |
Biomarin Pharmaceutical Inc | 15.6B | 76.6x | --- |
Qiagen NV | 9.1B | 27.3x | +12.66% |
United Therapeutics Corp | 11.1B | 11.8x | +8.22% |
Company Information
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company. The Company is engaged in discovering and developing treatments for patients with under-addressed neurological, neuroendocrine and neuropsychiatric disorders. Its diverse portfolio includes the United States Food and Drug Administration-approved treatments for tardive dyskinesia, chorea associated with Huntington’s disease, endometriosis and uterine fibroids, as well as a robust pipeline, including multiple compounds in mid-to late-phase clinical development across its core therapeutic areas. Its commercial products include INGREZZA, ALKINDI, EFMODY, Orilissa and Oriahnn. INGREZZA is marketed as DYSVAL (valbenazine) in Japan and REMLEAS (valbenazine) in other select Asian markets, where Mitsubishi Tanabe Pharma Corporation retains commercialization rights. ALKINDI is marketed as ALKINDI SPRINKLE (hydrocortisone) in the United States, where Eton Pharmaceuticals, Inc. retains commercialization rights.
Contact Information
- Headquarters
- 6027 EDGEWOOD BEND COURTSAN DIEGO, CA, United States 92130
- Phone
- 858-617-7600
- Fax
- 858-617-7602
Executives
- Non-Executive Independent Chairman of the Board
- William Rastetter
- Chief Executive Officer, Director
- Kevin Gorman
- Chief Financial Officer
- Matthew Abernethy
- Chief Human Resource Officer
- Julie Cooke
- Chief Scientific Officer
- Jude Onyia
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $13.9B |
|---|---|
Revenue (TTM) | $1.9B |
Shares Outstanding | 100.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.28 |
EPS | $2.43 |
Book Value | $22.61 |
P/E Ratio | 55.9x |
Price/Sales (TTM) | 7.3 |
Price/Cash Flow (TTM) | 51.1x |
Operating Margin | 13.30% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
